Skip to main navigation Skip to search Skip to main content

Improving Shared Decision-Making in Early Phase Clinical Trials and Palliative Care: A Prospective Study on the Impact of an Online Value Clarification Tool Intervention

  • Liza G. G. van Lent*
  • , Julia C. M. van Weert
  • , Maja J. A. de Jonge
  • , Mirte van der Ham
  • , Esther Oomen-de Hoop
  • , Martijn P. Lolkema
  • , Marjolein van Mil
  • , Eelke H. Gort
  • , Jelle van Gurp
  • , Jeroen Hasselaar
  • , Carin C. D. van der Rijt
  • *Corresponding author for this work
  • Erasmus University Rotterdam
  • University of Amsterdam
  • Amgen Incorporated
  • Netherlands Cancer Institute
  • Utrecht University
  • Radboud University Nijmegen

Research output: Contribution to journalArticleAcademicpeer-review

65 Downloads (Pure)

Abstract

Objectives: This study evaluated the impact of the OnVaCT intervention, a narrative-based Online Value Clarification Tool (OnVaCT), combined with communication training for oncologists, on shared decision-making (SDM) in discussions on potential early phase clinical trial participation and palliative care. These high-stakes decisions often challenge patients and oncologists in addressing patient values, a crucial component of SDM. We hypothesized that the intervention would improve oncologist-patient communication, specifically SDM application, and (consequently) reduce patient decisional conflict. Methods: In this prospective, multicentre pre-post clinical study, patients completed two surveys, and their recorded consultations on early phase clinical trials and palliative care were assessed by independent coders. Pre-intervention patients received usual care, while post-intervention patients used the OnVaCT. Oncologists underwent communication training between study phases. Endpoints included decisional conflict (primary), the extent to which oncologists, patients and relatives participate in SDM, consultation length, and patient decisions (secondary). Results: Decisional conflict (p = 0.394) did not differ between pre-test (n = 116, M = 30.0, SD = 16.9) and post-test (n = 99, M = 29.4, SD = 15.2). Oncologists significantly increased their SDM application post-intervention (p < 0.001; n = 129, M = 38.5, SD = 12.6) compared to pre-intervention (n = 163, M = 28.8, SD = 9.2), particularly when the OnVaCT was discussed. Other outcomes, including consultation length, remained stable. Conclusions: The OnVaCT intervention enhanced SDM and supported value-based discussions, without prolonging consultations. Further research should explore whether additional implementation efforts could reduce decisional conflict and the intervention's potential impact on other patient-centred outcomes. Some decisions, however, may inherently involve unresolved conflict.

Original languageEnglish
Article numbere70168
JournalPsycho-oncology
Volume34
Issue number5
DOIs
Publication statusPublished - 1 May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cancer
  • decisional conflict
  • early phase clinical trials
  • oncology
  • online tool
  • patient-provider communication
  • shared decision-making
  • value clarification

Fingerprint

Dive into the research topics of 'Improving Shared Decision-Making in Early Phase Clinical Trials and Palliative Care: A Prospective Study on the Impact of an Online Value Clarification Tool Intervention'. Together they form a unique fingerprint.

Cite this